The Editors' conflict of interest disclosure information is available here.
Associate Editors
ALLISON BETOF-WARNER, MD, PhD, Stanford University Medical Center
ALICIA MORGANS, MD, MPH , Dana-Farber Cancer Institute
OMID HAMID, MD, The Angeles Clinic, an affiliate of Cedars-Sinai
ANA GLEISNER, MD, University of Colorado Cancer Center
SUSAN PARSONS, MD, MRP, Tufts University School of Medicine
ANDREA ZIMMER, MD, University of Nebraska Medical Center
WILLIAM C. WOOD, MD, Winship Cancer Institute, Emory University
KAREN M. WINKFIELD, MD, PhD, Wake Forest School of Medicine
JAMIE H. VON ROENN, MD, American Society of Clinical Oncology
STEVEN E. VOGL, MD, Bronx, New York
VAMSI VELCHETI, MD, NYU Langone Health/Perlmutter Cancer Center
THOMAS J. SMITH, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SAMUEL SILVER, MD, PhD, University of Michigan Health System
ANDREW D. SEIDMAN, MD, Memorial Sloan Kettering Cancer Center
LEE S. SCHWARTZBERG, MD, University of Tennessee Health Science Center
RICHARD L. SCHILSKY, MD, FACP, FSCT, FASCO, Professor Emeritus, University of Chicago
MICHAEL A. ROTH, MD, The University of Texas MD Anderson Cancer Center
STEVEN T. ROSEN, MD, City of Hope National Medical Center
DEREK RAGHAVAN, MD, PhD, Levine Cancer Institute, Carolinas HealthCare System
DAVID PFISTER, MD, Memorial Sloan Kettering Cancer Center
JAMES L. MULSHINE, MD, Rush University Medical Center
URSULA A. MATULONIS, MD , Dana-Farber Cancer Institute
RAMI MANOCHAKIAN, MD, Mayo Clinic Florida
STUART LICHTMAN, MD, FACP, FASCO, Memorial Sloan Kettering Cancer Center–Commack, New York
ALLEN S. LICHTER, MD, Ann Arbor, Michigan
BONNIE KY, MD, MSCE, FACC, University of Pennsylvania, Philadelphia
PAMELA KUNZ, MD, Yale University School of Medicine, Yale Cancer Center
International Editors
YÜKSEL ÜRÜN, MD, Ankara University, Ankara, Turkey
DANIEL A. VOROBIOF, MD, Sandton Oncology Centre, Johannesburg, South Africa
JOHN F. SMYTH, MD, University of Edinburgh, Edinburgh, Scotland
NAGI EL-SAGHIR, MD, American University of Beirut, Lebanon
MIRIAM MUTEBI, MD, Aga Khan University, Nairobi, Kenya
CLARISSA MATHIAS, MD, NOB/Oncoclinicas, Salvador, Brazil
JACEK JASSEM, MD, Medical University of Gdansk, Poland
MARY GOSPODAROWICZ, MD, Princess Margaret Hospital, Toronto, Ontario, Canada
JEFF DUNN, PhD, AO, President, UICC; University of Southern Queensland in Australia,
VOLKER S. DIEHL, MD, FASCO, German Hodgkin Study Group , Cologne, Germany
RAKESH CHOPRA, MD, Medical Oncology & Hematology, New Delhi & Gurugram, India
EDUARDO CAZAP, MD, PhD, International Union Against Cancer (UICC), Buenos Aires, Argentina